Navigation Links
System to deliver organ transplant drug -- without harmful side effects
Date:1/26/2012

A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects, is being developed by scientists at the University of Strathclyde in Glasgow.

The drug, cyclosporine (CsA), is widely used in transplant operations and helps prevent the patient's body rejecting the organ but it can cause adverse drug reactions, of which the most serious problems are kidney and liver damage, in the doses which are currently administered in the long term.

The gap between a safe, effective dose of the treatment and a toxic dose is extremely narrow but the Strathclyde scientists have found a way of capturing CsA in very small amounts. The new system, developed in laboratory tests, enables nanoparticles of the drug to be delivered orally so that the strength of the dose can be maintained, but at a level and in a form which spares kidneys from damage.

Professor Ravi Kumar, of the Strathclyde Institute of Pharmacy and Biomedical Sciences, led the research. He said: "CsA is very useful in transplants and treating conditions such as arthritis, lupus and some forms of diabetes, but we need to address the risks it can present to the kidney and liver, apart from various other toxicities such as convulsions and high blood pressure.

"The damage it can cause can be dealt with if it's caught at an early stage but can be irreversible if it continues unchecked. Furthermore, existing formulations of cyclosporine contain castor oil-based vehicle which is used owing to the drug's poor solubility in water but which can be toxic.

"By entrapping CsA in nanoparticles, we aimed to match the maximum concentration of the most potent formulation of the drug in market. In tests, we were able to strike a balance between strength, efficacy and safety and were able to make a marked increase in the drug's bioavailability- the level of the drug which becomes active in the system.

"We were also able
'/>"/>

Contact: Paul Gallagher
corporatecomms@strath.ac.uk
44-141-548-2370
University of Strathclyde
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Ingenuity Systems iReport Now Available: Fast, Accurate, Interactive Report for Gene Expression Data
2. Diverse ecosystems are crucial climate change buffer
3. Breakthrough model reveals evolution of ancient nervous systems through seashell colors
4. Gut microbe networks differ from norm in obese people, systems biology approach reveals
5. UGA scientists hijack bacterial immune system
6. Autism may be linked to abnormal immune system characteristics and novel protein fragment
7. Researcher contends multiple sclerosis is not a disease of the immune system
8. An ecosystem being transformed - Yellowstone 15 years after the return of wolves
9. VeriLook Surveillance 2.0 SDK Advances Face Recognition for Large, Multi-Camera Video Surveillance Systems
10. Industry, regulators should take system safety approach to offshore drilling in aftermath of Deepwater Horizon accident, says new report
11. Improved rainwater harvesting system promising
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
System to deliver organ transplant drug -- without harmful side effects
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/23/2015)... March 23, 2015 SoundView Technology Group issues a ... NXTD ) Wocket smart wallet. SoundView was one of the ... their experience with the Wocket in multiple scenarios and outlets. ... Foods and other retailers, making both debit and credit card ... also says, "If the company meets their plans in 2015, ...
(Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... available in Spanish . , AZTI-Tecnalia ... promotion of zebrafish as an animal model in all ... has the support of the Spanish Ministry of Science ... administered by a Management Board formed by AZTI-Tecnalia, the ...
... of Liverpool scientists claim that the degeneration of sight, caused ... to 20% by increasing the amount of fruit, vegetables and ... the leading cause of blindness in the UK, with 45% ... The condition results in a gradual loss of central vision, ...
... The Integrated Ocean Drilling Program (IODP) will conduct ... its platforms in 2009, from March until December. ... operations in 2004 that all three platforms will ... be conducted aboard the Chikyu; the newly modernized ...
Cached Biology News:AZTI-Tecnalia coordinates a platform promoting the use of zebrafish in scientific research 2Diet could reduce onset of eye disease by 20 percent 2IODP to operate 3 drilling platforms in 2009 2
(Date:4/23/2015)... 23, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... first quarter 2015 results before the Nasdaq market opens ... a live conference call and webcast to discuss its financial ... 30, 2015 at 8:00 a.m. Eastern Time (5:00 a.m. ... conference call by dialing 866-952-1906 (US) or 785-424-1825 (International) ...
(Date:4/23/2015)... Calif. , April 23, 2015  Veracyte, Inc. (NASDAQ: ... into a definitive agreement to sell approximately $40 million ... the agreement, the investors will purchase an aggregate of ... of $8.15 per share, the closing stock price on ... new and existing investors, including Broadfin Capital, Camber Capital, ...
(Date:4/23/2015)... HOUSTON , April 23, 2015  Metanome, ... today announced the company has changed its name ... reflect Diversigen,s positioning as the single commercial source ... need to capitalize on the diverse opportunities of ... types that Diversigen accepts – including those that ...
(Date:4/23/2015)... (PRWEB) April 23, 2015 Delpor, Inc. ... announced that the United States Patent and Trademark Office ... NANOPORâ„¢ technology. US Pat. No. 8,986,727 ... microfabricated drug delivery device for the sustained ... NANOPORâ„¢ technology for the sustained (zero-order) release of large ...
Breaking Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4Metanome Announces Corporate Name Change to Diversigen 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3
... , PALO ALTO, Calif., August 4, 2009 ... announced today that it has licensed the exclusive worldwide rights ... This technology, discovered in the lab of Stanford scientist and ... a variety of novel targets, including key features of NS4B, ...
... , , , MOUNTAIN VIEW, ... a pharmaceutical company dedicated to the development and commercialization of novel ... present an overview of the company at the Canaccord Adams 29th ... The VIVUS presentation will take place at the Intercontinental ...
... MINNEAPOLIS, Aug. 4 Techne Corporation,s (Nasdaq: ... 2009 decreased 6.9% to $25.4 million or $.68 per diluted share ... quarter ended June 30, 2008. For the fiscal year ended June ... or $2.78 per diluted share compared with $103.6 million or $2.64 ...
Cached Biology Technology:Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University 2VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference 2Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009 2Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009 3Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009 4Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009 5Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009 6Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009 7
... is a modified cap analog in which ... is replaced with OCH3. Because of this ... transcription with the remaining hydroxyl group thus ... As a result, unlike transcripts synthesized with ...
... called a ?cap? is present on ... mRNAs and many viral RNAs. Substitution ... of the GTP present in an ... the synthesis of transcripts with a ...
... structure called a ?cap? is present ... eukaryotic mRNAs and many viral RNAs. ... portion of the GTP present in ... in the synthesis of transcripts with ...
... A modified nucleotide structure called a ... of most naturally-occurring eukaryotic mRNAs and ... Analog for a portion of the ... transcription reaction results in the synthesis ...
Biology Products: